About Biosector 2
At Biosector 2 (B2), we are immersed in the ever changing marketplace to make a meaningful impact when treatment and health decisions are being made. We are healthcare communications specialists known for telling the right brand and disease state story at the right time and place.
We offer best-in-class communications strategy, digital and social media, issues management, stakeholder engagement, and analytics and measurement. We’ve launched award-winning public health campaigns across advocacy, trade and B2B strategic partnerships, launched groundbreaking social media programs, including the first product-branded Twitter channel, and excel in innovative scientific communications for our clients.
B2 is part of INC Research/inVentiv Health, an industry-changing new company, purpose-built to help the industry achieve a singular goal: Biopharmaceutical Acceleration. The coming together of two dedicated businesses allows us to address new market realities through clinical and commercial sharing expertise, data and insights to meet the needs of global biopharmaceutical companies of all sizes to speed the delivery of therapies to patients worldwide.